VEEVA SYSTEMS INC CLASS A (VEEV)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for VEEV
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| VEEV | ["delivers important insight","co-founder of Veeva","deep knowledge of Veeva","life sciences technology expertise","deep knowledge of and relationships with customers"] | ["Nominating and Governance Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Age: 53 Director since 2020 Independent Director* Committee Nominating and Governance Qualifications Deep knowledge of Veeva as co-founder and former President Experience as an executive and business leader in the life sciences technology industry Career Experience 2025 present: Co-founder and Partner, Proofpoint Capital, a venture capital firm 2007 2019: Co-founder and President, Veeva Systems Inc. 2005 2007: Chief Marketing Officer, Health Market Science, Inc., a supplier of healthcare data solutions 2004: Vice President of Marketing and Product Management, IntelliChem, Inc., a provider of scientific content management solutions 1998 2003: General Manager, Pharmaceuticals & Biotechnology division, Siebel Systems, Inc., a customer relationship management software company Selected Board Experience HealthVerity, Inc. (2016 present) Education Bachelor of Arts, Economics, Yale University Master of Business Administration, Harvard Business School * Our Board determined that Mr. Wallach is an independent director under NYSE listing standards. While Mr. Wallach is a co-founder of Veeva, he has not been employed by the Company for over six years and he is financially and socially independent from Veeva and current Veeva executives. Mr. Wallach s deep knowledge of Veeva, coupled with his life sciences technology expertise and deep knowledge of and relationships with our customers, makes him an important contributor to our Board s leadership on strategy, risk management, and governance. For more information, see How We Are Selected, Elected, and Evaluated Director Independence .